A holistic approach to targeting disease with polymeric nanoparticles
Open accessThe DOI matches its Crossref record; 135 of the 135 references it cites were found in a registry or an index.
Abstract
The primary goal of nanomedicine is to improve clinical outcomes. To this end, targeted nanoparticles are engineered to reduce non-productive distribution while improving diagnostic and therapeutic efficacy. Paradoxically, as this field has matured, the notion of targeting has been minimized to the concept of increasing the affinity of a nanoparticle for its target. This Opinion article outlines a holistic view of nanoparticle targeting, in which the route of administration, molecular characteristics and temporal control of the nanoparticles are potential design variables that must be considered simultaneously. This comprehensive vision for nanoparticle targeting will facilitate the integration of nanomedicines into clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Encapsulation of hepcidin into biocompatible nanocarriers suitable for controlled release of therapeutics (Cheng et al., 2015) could theoretically address this issue.”
From Pharmacological Targeting of the Hepcidin/Ferroportin Axis (2016) · cites this paper as Cheng et al., 2015
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biodegradable polymeric nanoparticles as drug delivery devices
Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R., & Rudzinski, W. E. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00339-4 · Cited by 3,549
Biomolecular coronas provide the biological identity of nanosized materials
Monopoli, M. P., Åberg, C., Salvati, A., & Dawson, K. A. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.207 · Cited by 3,017
Bertrand, N., Wu, J., Xu, X., Kamaly, N., & Farokhzad, O. C. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.009 · Cited by 2,824
Effect of Surface Properties on Nanoparticle–Cell Interactions
Verma, A., & Stellacci, F. (2010) · Small · doi:10.1002/smll.200901158 · Cited by 2,619
He, C., Hu, Y., Yin, L., Tang, C., & Yin, C. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.01.065 · Cited by 2,607
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Davis, M. E., Zuckerman, J. E., Choi, C. H. J., Seligson, D., Tolcher, A., Alabi, C. A., Yen, Y., Heidel, J. D., & Ribas, A. (2010) · Nature · doi:10.1038/nature08956 · Cited by 2,505
Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology
Tenzer, S., Docter, D., Kuharev, J., Musyanovych, A., Fetz, V., Hecht, R., Schlenk, F., Fischer, D., Kiouptsi, K., Reinhardt, C., et al. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2013.181 · Cited by 2,283
Sahay, G., Alakhova, D. Y., & Kabanov, A. V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.01.036 · Cited by 2,181
Salvati, A., Pitek, A. S., Monopoli, M. P., Prapainop, K., Bombelli, F. B., Hristov, D. R., Kelly, P. M., Åberg, C., Mahon, E., & Dawson, K. A. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2012.237 · Cited by 1,912
Exploiting the enhanced permeability and retention effect for tumor targeting
Iyer, A. K., Khaled, G., Fang, J., & Maeda, H. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.07.005 · Cited by 1,846
Research works printed but not linked: 5
- Bertrand N Leroux JC The journey of a drug-carrier in the body: an anatomo-physiological perspective Journal of Controlled Release: Official Journal of the Controlled Release Society 161 152 163 2012 22001607
- Davis ME Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles Nature 464 1067 U140 2010 20305636 PMC2855406
- Wang YC Sustained intraspinal delivery of neurotrophic factor encapsulated in biodegradable nanoparticles following contusive spinal cord injury Biomaterials 29 4546 4553 2008 18774604
- Kaur IP Kakkar S Nanotherapy for posterior eye diseases Journal of Controlled Release: Official Journal of the Controlled Release Society 2014 24862316
- Li H A PEDF N-terminal peptide protects the retina from ischemic injury when delivered in PLGA nanospheres Experimental Eye Research 83 824 833 2006 16822505
Cited by
Items 101–200 of 492
The Nanopharmacology and Nanotoxicology of Nanomaterials: New Opportunities and Challenges
Radomska, A., Leszczyszyn, J., & Radomski, M. W. (2016) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/60879 · Cited by 108
Smart nanosystems: Bio-inspired technologies that interact with the host environment
Kwon, E. J., Lo, J. H.-J., & Bhatia, S. N. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1508522112 · Cited by 101
Feng, S., Hu, Y., Peng, S., Han, S., Tao, H., Zhang, Q., Xu, X., Zhang, J., & Hu, H. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.08.003 · Cited by 95
Enhancing the In Vitro and In Vivo Stabilities of Polymeric Nucleic Acid Delivery Nanosystems
Wang, Y., Ye, M., Xie, R., & Gong, S. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00749 · Cited by 92
Wang, J., Zhao, H., Zhi, K., & Yang, X. H. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b18443 · Cited by 94
Nanomedicine for Ischemic Stroke
Dong, X., Gao, J., Su, Y., & Wang, Z. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207600 · Cited by 94
Transport phenomena of nanoparticles in plants and animals/humans
Anjum, N. A., Rodrigo, M. Á. M., Moulick, A., Heger, Z., Kopel, P., Zítka, O., Adam, V., Lukatkin, A. S., Duarte, A. C., Pereira, E., et al. (2016) · Environmental Research · doi:10.1016/j.envres.2016.07.018 · Cited by 95
Functional polyesters enable selective siRNA delivery to lung cancer over matched normal cells
Yan, Y., Liu, L., Xiong, H., Miller, J. B., Zhou, K., Kos, P., Huffman, K. E., Elkassih, S., Norman, J. W., Carstens, R., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1606886113 · Cited by 88
Plasmonic Nanoparticles with Supramolecular Recognition
Mosquera, J., Zhao, Y., Jang, H., Xie, N., Xu, C., Kotov, N. A., & Liz‐Marzán, L. M. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201902082 · Cited by 90
Luo, M., Lee, L. K. C., Peng, B., Choi, C. H. J., Tong, W. Y., & Voelcker, N. H. (2022) · Advanced Science · doi:10.1002/advs.202201740 · Cited by 92
Neutrophil‐Based Delivery Systems for Nanotherapeutics
Han, Y., Zhao, R., & Xu, F. (2018) · Small · doi:10.1002/smll.201801674 · Cited by 94
Feng, T., Tang, Z., Karges, J., Shen, J., Jin, C., Chen, Y., Pan, Y., He, Y., Ji, L., & Chao, H. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122212 · Cited by 89
Bacterial cellulose based composites enhanced transdermal drug targeting for breast cancer treatment
Zhang, L., Du, S., Wang, X., Jiao, Y., Yin, L., Zhang, Y., & Guan, Y. (2019) · Chemical Engineering Journal · doi:10.1016/j.cej.2019.03.216 · Cited by 88
Emerging strategies in developing multifunctional nanomaterials for cancer nanotheranostics
Ang, M. J. Y., Chan, S. Y., Goh, Y. Y., Luo, Z., Lau, J. W., & Liu, X. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113907 · Cited by 91
Improved i.p. drug delivery with bioadhesive nanoparticles
Deng, Y., Yang, F., Cocco, E., Song, E., Zhang, J., Cui, J., Mohideen, M., Bellone, S., Santin, A. D., & Saltzman, W. M. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1523141113 · Cited by 87
Self-citationYi, Y., Lin, G., Chen, S., Liu, J., Zhang, H., & Mi, P. (2017) · Materials Science and Engineering C · doi:10.1016/j.msec.2017.10.004 · Cited by 86
Ex-vivo Kidney Machine Perfusion: Therapeutic Potential
Žulpaitė, R., Miknevicius, P., Leber, B., Strupas, K., Stiegler, P., & Schemmer, P. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.808719 · Cited by 91
Elgqvist, J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18051102 · Cited by 90
Truong, N. P., Whittaker, M. R., Anastasaki, A., Haddleton, D. M., Quinn, J. F., & Davis, T. P. (2016) · Polymer Chemistry · doi:10.1039/c5py01467k · Cited by 86
Khor, S. Y., Vu, M. N., Pilkington, E. H., Johnston, A. P. R., Whittaker, M. R., Quinn, J. F., Truong, N. P., & Davis, T. P. (2018) · Small · doi:10.1002/smll.201801702 · Cited by 80
Polymer‐mediated gene therapy: Recent advances and merging of delivery techniques
Salameh, J. W., Zhou, L., Ward, S. M., Chalarca, C. F. S., Emrick, T. S., & Figueiredo, M. L. (2019) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1598 · Cited by 88
Oral Drug Delivery Technologies—A Decade of Developments
Kaur, G., Arora, M., & Kumar, M. N. V. R. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.255828 · Cited by 83
Therapeutic potential of hepcidin − the master regulator of iron metabolism
Vyoral, D., & Petrák, J. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.11.010 · Cited by 85
Santos, F. M. F., Rosa, J. N., Candeias, N. R., Carvalho, C. P., Matos, A. I., Ventura, A. E., Florindo, H. F., Silva, L. C., Pischel, U., & Góis, P. M. P. (2015) · Chemistry - A European Journal · doi:10.1002/chem.201503943 · Cited by 83
The future of marginal kidney repair in the context of normothermic machine perfusion
DiRito, J. R., Hosgood, S. A., Tietjen, G. T., & Nicholson, M. L. (2018) · American Journal of Transplantation · doi:10.1111/ajt.14963 · Cited by 77
Self-citationChen, W., Zhou, Y., Zhi, X., Ma, T., Liu, H., Chen, B. W., Zheng, X., Xie, S., Zhao, B., Feng, X., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.11.035 · Cited by 77
Cancer chemoprevention: signaling pathways and strategic approaches
Ren, J., Yan, G., Yang, L., Kong, L., Guan, Y., Sun, H., Liu, C., Liu, L., Han, Y., & Wang, X. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02167-1 · Cited by 84
Allosteric effects of gold nanoparticles on human serum albumin
Shao, Q., & Hall, C. K. (2016) · Nanoscale · doi:10.1039/c6nr07665c · Cited by 75
Xin, X., Lin, F., Wang, Q., Yin, L., & Mahato, R. I. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b02756 · Cited by 75
Bioactive nanotherapeutic trends to combat triple negative breast cancer
Chowdhury, P., Ghosh, U., Samanta, K., Jaggi, M., Chauhan, S. C., & Yallapu, M. M. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.02.037 · Cited by 84
Aliyandi, A., Reker‐Smit, C., Bron, R., Zuhorn, I. S., & Salvati, A. L. (2021) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.1c00804 · Cited by 76
Yang, B., Dong, X., Lei, Q., Zhuo, R., Feng, J. X., & Zhang, X. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b07549 · Cited by 70
Tumor Exosome Mimicking Nanoparticles for Tumor Combinatorial Chemo-Photothermal Therapy
Tian, R., Wang, Z., Niu, R., Wang, H., Guan, W., & Chang, J. K. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.01010 · Cited by 73
Nanoengineering of Poly(ethylene glycol) Particles for Stealth and Targeting
Cui, J., Björnmalm, M., Ju, Y., & Caruso, F. (2018) · Langmuir · doi:10.1021/acs.langmuir.8b02117 · Cited by 72
Using Large Datasets to Understand Nanotechnology
Paunovska, K., Loughrey, D., Sago, C. D., Langer, R., & Dahlman, J. E. (2019) · Advanced Materials · doi:10.1002/adma.201902798 · Cited by 73
Polypeptide‐Based Conjugates as Therapeutics: Opportunities and Challenges
Zagorodko, O., Arroyo‐Crespo, J. J., Nebot, V. J., & Vicent, M. J. (2016) · Macromolecular Bioscience · doi:10.1002/mabi.201600316 · Cited by 71
Advances in Biogenic Nanoparticles and the Mechanisms of antimicrobial Effects
Qidwai, A., Pandey, A. K., Kumar, R., Shukla, S. K., & Dikshit, A. (2018) · Indian Journal of Pharmaceutical Sciences · doi:10.4172/pharmaceutical-sciences.1000398 · Cited by 68
Jiang, W., Chen, J., Gong, C., Wang, Y., Gao, Y., & Yuan, Y. (2020) · Journal of Nanobiotechnology · doi:10.1186/s12951-020-00607-4 · Cited by 67
Feng, T., Tang, Z., Karges, J., Shu, J., Xiong, K., Jin, C., Chen, Y., Gasser, G., Ji, L., & Chao, H. (2024) · Chemical Science · doi:10.1039/d4sc01214c · Cited by 67
Surfactant-free RAFT emulsion polymerization using a novel biocompatible thermoresponsive polymer
Truong, N. P., Quinn, J. F., Anastasaki, A., Rolland, M., Vu, M. N., Haddleton, D. M., Whittaker, M. R., & Davis, T. P. (2017) · Polymer Chemistry · doi:10.1039/c6py02158a · Cited by 66
Relay Drug Delivery for Amplifying Targeting Signal and Enhancing Anticancer Efficacy
Hu, Q., Sun, W., Qian, C., Bomba, H. N., Xin, H., & Gu, Z. (2017) · Advanced Materials · doi:10.1002/adma.201605803 · Cited by 66
Almajidi, Y. Q., Gupta, J., Sheri, F. S., Zabibah, R. S., Faisal, A., Ruzibayev, A. T., Adil, M., Saadh, M. J., Jawad, M. J., Alsaikhan, F., et al. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.127278 · Cited by 70
Increasing the Impact of Materials in and beyond Bio-Nano Science
Björnmalm, M., Faria, M., & Caruso, F. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b08673 · Cited by 67
Cell‐Membrane‐Display Nanotechnology
Wang, Y., Zhang, P., Wei, Y., Shen, K., Xiao, L., Miron, R. J., & Zhang, Y. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.202001014 · Cited by 65
Lysosomal nanotoxicity: Impact of nanomedicines on lysosomal function
Uzhytchak, M., Smolková, B., Lunová, M., Frtús, A., Jirsa, M., Dejneka, A., & Lunov, O. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114828 · Cited by 65
Breaking biological barriers: Engineering polymeric nanoparticles for cancer therapy
Austria, E. S., Jr., Bilek, M., Varamini, P., & Akhavan, B. (2024) · Nano Today · doi:10.1016/j.nantod.2024.102552 · Cited by 66
Setia, A., Mehata, A. K., Vikas, V., Malik, A. K., Viswanadh, M. K., & Muthu, M. S. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104295 · Cited by 81
Lung Cancer Nanomedicine: Potentials and Pitfalls
Bölükbas, D. A., & Meiners, S. (2015) · Nanomedicine · doi:10.2217/nnm.15.155 · Cited by 64
Recent advances in the targeted delivery of paclitaxel nanomedicine for cancer therapy
Raza, F., Zafar, H., Khan, M. W., Ullah, A., Khan, A. U., Baseer, A., Fareed, R., & Sohail, M. (2021) · Materials Advances · doi:10.1039/d1ma00961c · Cited by 61
Siddique, M. I., Katas, H., Jamil, A., Amin, M. C. I. M., Ng, S., Zulfakar, M. H., & Nadeem, S. M. (2017) · Drug Delivery and Translational Research · doi:10.1007/s13346-017-0439-7 · Cited by 61
Targeting Oxidative Stress Using Nanoparticles as a Theranostic Strategy for Cardiovascular Diseases
Kim, K. S., Song, C. G., & Kang, P. M. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7428 · Cited by 62
Efficient encapsulation of biocompatible nanoparticles in exosomes for cancer theranostics
Tanziela, T., Shaikh, S. A., Jiang, H., Lu, Z., & Wang, X. (2020) · Nano Today · doi:10.1016/j.nantod.2020.100964 · Cited by 60
Henzler, K. D., Heilemann, A., Kneer, J., Guttmann, P., Jia, H., Bartsch, E., Lu, Y. Q., & Palzer, S. (2015) · Scientific Reports · doi:10.1038/srep17729 · Cited by 60
Klepac, D., Kostková, H., Petrova, S. L., Chytil, P., Etrych, T., Kereïche, S., Raška, I., Weitz, D. A., & Filippov, S. K. (2018) · Nanoscale · doi:10.1039/c7nr09355a · Cited by 62
Badiee, P., Varshochian, R., Rafiee‐Tehrani, M., Dorkoosh, F. A., Khoshayand, M. R., & Dinarvand, R. (2018) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36424 · Cited by 62
Gold-Polymer Nanocomposites for Future Therapeutic and Tissue Engineering Applications
Kumar, P. P. P., & Lim, D. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics14010070 · Cited by 62
Silk nanoparticles: proof of lysosomotropic anticancer drug delivery at single-cell resolution
Totten, J. D., Wongpinyochit, T., & Seib, F. P. (2017) · Journal of drug targeting · doi:10.1080/1061186x.2017.1363212 · Cited by 58
Hao, F., Lee, R. J., Zhong, L., Dong, S., Yang, C., Teng, L., Meng, Q., 陆嘉惠, Xie, J., & Teng, L. (2019) · Theranostics · doi:10.7150/thno.32268 · Cited by 58
Wang, X., Sheng, J., & Yang, M. (2018) · Chinese Chemical Letters · doi:10.1016/j.cclet.2018.10.010 · Cited by 60
Trophoblast-Targeted Nanomedicine Modulates Placental sFLT1 for Preeclampsia Treatment
Li, L., Yang, H., Chen, P., Xin, T., Zhou, Q., Wei, D., Zhang, Y., & Wang, S. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00064 · Cited by 56
Sasidharan, S., Bahadur, D., & Srivastava, R. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b03428 · Cited by 56
Duro‐Castaño, A., Nebot, V. J., Niño‐Pariente, A., Armiñán, A., Arroyo‐Crespo, J. J., Paul, A., Feiner‐Gracia, N., Albertazzi, L., & Vicent, M. J. (2017) · Advanced Materials · doi:10.1002/adma.201702888 · Cited by 58
Koshkina, O., Westmeier, D., Lang, T., Bantz, C., Hahlbrock, A., Würth, C., Resch‐Genger, U., Braun, U., Thiermann, R., Weise, C., et al. (2016) · Macromolecular Bioscience · doi:10.1002/mabi.201600074 · Cited by 58
Design of a novel curcumin-soybean phosphatidylcholine complex-based targeted drug delivery systems
Jiajiang, X., Li, Y., Song, L., Pan, Z., Ye, S., & Hou, Z. (2017) · Drug Delivery · doi:10.1080/10717544.2017.1303855 · Cited by 56
Gao, J., Wang, S., Dong, X., & Wang, Z. (2021) · Theranostics · doi:10.7150/thno.51988 · Cited by 57
Feng, R., Yu, F., Xu, J., & Hu, X. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120469 · Cited by 55
Xu, M., Zhang, C., He, S., Xu, C., Wei, X., & Pu, K. (2023) · ACS Nano · doi:10.1021/acsnano.2c12066 · Cited by 54
Quantification of intracellular payload release from polymersome nanoparticles
Scarpa, E., Bailey, J. L., Janeczek, A. A., Stumpf, P. S., Johnston, A. H., Oreffo, R. O. C., Woo, Y. L., Cheong, Y. C., Evans, N. D., & Newman, T. A. (2016) · Scientific Reports · doi:10.1038/srep29460 · Cited by 57
Andreozzi, P., Diamanti, E., Py-Daniel, K. R., Cáceres‐Vélez, P. R., Martinelli, C., Πολιτάκος, Ν., Escobar, A., Muzi-Falconi, M., Azevedo, R. B., & Moya, S. E. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b11132 · Cited by 56
Lunová, M., Prokhorov, A., Jirsa, M., Hof, M., Olżyńska, A., Jurkiewicz, P., Kubinová, Š., Lunov, O., & Dejneka, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-16447-6 · Cited by 54
Neutrophil mediated drug delivery for targeted glioblastoma therapy: A comprehensive review
Hosseinalizadeh, H., Mahmoodpour, M., Bahabadi, Z. R., Hamblin, M. R., & Mirzaei, H. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113841 · Cited by 53
Wei, C., Ya, X., Shen, Q., Li, R., Xiao, X., Saw, P. E., & Xu, X. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.07.009 · Cited by 53
Tailoring biomaterials for vaccine delivery
Zhuo, Y., Zeng, H., Su, C., Lv, Q., Cheng, T., & Lei, L. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02758-0 · Cited by 53
Kotla, N. G., Burke, Ó., Pandit, A. S., & Rochev, Y. A. (2019) · Nanomaterials · doi:10.3390/nano9091246 · Cited by 52
Wu, Y., Tang, Y., Xie, S., Zheng, X., Zhang, S., Mao, J., Wang, B., Hou, Y., Hu, L., Chai, K., et al. (2019) · Theranostics · doi:10.7150/thno.38327 · Cited by 53
Tan, J., Deng, Z., Song, C., Xu, J., Zhang, Y., Yu, Y. H., Hu, J., & Liu, S. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.1c05617 · Cited by 52
Recent Progress in Carbon Nanotube Polymer Composites in Tissue Engineering and Regeneration
Gangadhar, L., Sana, S. S., Nguyen, V.-H., Nguyen, T. H. C., Nguyen, C. C., Le, Q. V., & Peng, W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176440 · Cited by 51
Controlling the morphology of copolymeric vectors for next generation nanomedicine
Williams, D. S., Pijpers, I. A. B., Ridolfo, R., & van Hest, J. C. M. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.02.030 · Cited by 53
Biomedical applications of functional peptides in nano-systems
Rong, L., Qin, S., Zhang, C., Cheng, Y., Feng, J. X., Wang, S., & Zhang, X. (2018) · Materials Today Chemistry · doi:10.1016/j.mtchem.2018.06.001 · Cited by 52
Nanotechnology Applications in Transplantation Medicine
Yao, C. G., & Martins, P. N. A. (2019) · Transplantation · doi:10.1097/tp.0000000000003032 · Cited by 53
TRAIL in the Treatment of Cancer: From Soluble Cytokine to Nanosystems
Zeinabad, H. A., & Szegezdi, É. (2022) · Cancers · doi:10.3390/cancers14205125 · Cited by 50
Xiao, C., Fan, L., Zhou, S., Kang, X., Guan, P., Fu, R., Li, C., Ren, J. M., Wang, Z., Yu, P., et al. (2022) · ACS Nano · doi:10.1021/acsnano.2c07900 · Cited by 49
El-Baz, N., Nunn, B. M., Bates, P. J., & O’Toole, M. G. (2022) · Bioengineering · doi:10.3390/bioengineering9120766 · Cited by 48
Polymeric nanocarriers delivery systems in ischemic stroke for targeted therapeutic strategies
Zhu, L., Zhong, W., Meng, X., Yang, X., Zhang, W., Tian, Y., & Li, Y. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02673-4 · Cited by 50
Misinterpretation in Nanotoxicology: A Personal Perspective
Alkilany, A. M., Mahmoud, N. N., Hashemi, F., Hajipour, M. J., Farvadi, F., & Mahmoudi, M. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00108 · Cited by 52
Meghani, N. M., Amin, H. H., Park, C., Park, J.-B., Cui, J.-H., Cao, Q., & Lee, B. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.04.047 · Cited by 48
Bensouiki, S., Belaib, F., Sindt, M., Rup-Jacques, S., Magri, P., Ikhlef, A., & Méniai, A.-H. (2021) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2021.131298 · Cited by 48
Karam, M., Fahs, D., Maatouk, B. I., Safi, B., Jaffa, A. A., & Mhanna, R. (2022) · Materials Today Bio · doi:10.1016/j.mtbio.2022.100249 · Cited by 47
Malekpour, K., Hazrati, A., Khosrojerdi, A., Roshangar, L., & Ahmadi, M. (2023) · Regenerative Therapy · doi:10.1016/j.reth.2023.10.006 · Cited by 50
When Is It Important to Measure Unbound Drug in Evaluating Nanomedicine Pharmacokinetics?
Stern, S. T., Martinez, M. N., & Stevens, D. M. (2016) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.073148 · Cited by 47
In Vivo Delivery and Therapeutic Effects of a MicroRNA on Colorectal Liver Metastases
Oshima, G., Guo, N., He, C., Stack, M. E., Poon, C. J., Uppal, A., Wightman, S. C., Parekh, A. D., Skowron, K. B., Posner, M. C., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.04.005 · Cited by 47
Wadajkar, A. S., Dancy, J. G., Roberts, N. B., Connolly, N. P., Strickland, D. K., Winkles, J. A., Woodworth, G. F., & Kim, A. J. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.09.006 · Cited by 47
Liu, Y., Tang, Y., Tian, Y., Wu, J., Sun, J., Teng, Z., Wang, S., & Lu, G. (2019) · ACS Applied Nano Materials · doi:10.1021/acsanm.8b02036 · Cited by 47
A review on albumin as a biomaterial for ocular drug delivery
Tiwari, R., Sethiya, N. K., Gulbake, A. S., Mehra, N. K., Murty, U. S. N., & Gulbake, A. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.09.112 · Cited by 48
Polymer nanotherapeutics: A versatile platform for effective rheumatoid arthritis therapy
Nooreen, R., Nene, S., Jain, H., Prasannanjaneyulu, V., Chitlangya, P., Otavi, S., Khatri, D. K., Raghuvanshi, R. S., Singh, S. B., & Srivastava, S. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.05.054 · Cited by 47
Nanocarrier-Based Targeted Therapies for Myocardial Infarction
George, T. A., Hsu, C.-C., Meeson, A. P., & Lundy, D. J. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14050930 · Cited by 48
Pharmacological modulation of mitochondrial calcium homeostasis
Arduíno, D. M., & Perocchi, F. (2018) · The Journal of Physiology · doi:10.1113/jp274959 · Cited by 46
Kuruvilla, S. P., Tiruchinapally, G., Crouch, A. C., ElSayed, M. E. H., & Greve, J. M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181944 · Cited by 44
Vidal, F., Vásquez, P., Cayumán, F., Díaz, C. F., Fuentealba, J., Aguayo, L. G., Yévenes, G. E., Alderete, J. B., & Guzmán, L. (2017) · Nanomaterials · doi:10.3390/nano8010007 · Cited by 43
Niu, Y., Stadler, F. J., Song, J., Chen, S., & Chen, S. (2017) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2017.02.018 · Cited by 41
Metadata
- Authors
- Cheng, C. J., Tietjen, G. T., Saucier-Sawyer, J. K., & Saltzman, W. M.
- Affiliations
- Yale University (US)
- Corresponding author
- Saltzman, W. Mark
- Venue
- Nature Reviews Drug Discovery
- Published
- 2015-01-19
- Volume
- 14
- Issue
- 4
- Pages
- 239-247
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- PMC
- PMC4451203
- OpenAlex
- W2041271505
- Cited by
- 480
- References
- 135
- Citations by year
- 2026: 13 · 2025: 37 · 2024: 31 · 2023: 41 · 2022: 42 · 2021: 37 · 2020: 42 · 2019: 40 · 2018: 46 · 2017: 63 · 2016: 60 · 2015: 27
- FWCI
- 3.94
- Type
- journal article
- Language
- en
- Update notices
- erratum (2015-04-30)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (T32HL007974)
- National Cancer Institute (R01CA149128, F32CA174247, CA149128)
- National Institute of Allergy and Infectious Diseases (R01AI112443, T32AI089704, AI106992, R56AI106922, AI112443)
- National Institute of Biomedical Imaging and Bioengineering (EB00487, R01EB000487)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- targeted drug delivery, polymeric nanoparticles, nanomedicine, nanoparticle targeting, route of administration, nanoparticle design, clinical translation
- MeSH terms
- Animals, Humans, Polymers, Drug Delivery Systems, Nanomedicine, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.